Bosentan for Cutaneous Ulcers in Anti-MDA5 Dermatomyositis

JAMA Dermatol. 2018 Mar 1;154(3):371-373. doi: 10.1001/jamadermatol.2017.5462.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antihypertensive Agents / therapeutic use*
  • Autoantibodies / blood*
  • Bosentan / therapeutic use*
  • Dermatomyositis / blood
  • Dermatomyositis / complications*
  • Female
  • Humans
  • Interferon-Induced Helicase, IFIH1 / immunology*
  • Skin Ulcer / drug therapy*
  • Skin Ulcer / etiology

Substances

  • Antihypertensive Agents
  • Autoantibodies
  • IFIH1 protein, human
  • Interferon-Induced Helicase, IFIH1
  • Bosentan